Optimi Health Corp. (OPTH)
Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market. Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.
Sector: Pharmaceutical Preparations
Industry: Drug Manufacturers - Specialty & Generic
Optimi Health Corp.
NASDAQ:OPTHHealthcare · Drug Manufacturers - Specialty & Generic
AHAfter hours-4.63%$2.38
Prev close$2.34+6.84%Close$2.50-4.63%Now$2.38
Close$2.50+6.84%
Mkt Cap$14.31M
Float4.88M
O/S5.73M
VOL33K sh
$ Vol$77K
RVOL0.90×
Inst Own10.7%
SI0.5%
Dilution
Financials Summary
Revenue$427K
Net Income-$3.72M
Total Assets$15.23M
Free Cash Flow-$2.72M
Debt & Equity
Debt 50%
Equity 50%
Total Debt$6.69M
Total Equity$6.58M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
2-year cumulative
1:30
Nasdaq bars a compliance period at 1:250
- 1:30Reverse splitMay 20, 202630 shares → 1
Balance Sheet Details
Assets$15.23M
Liabilities$8.65M
Accounts Receivable$95K
Accounts Payable$1.19M
Inventory$311K
PP&E (Net)$12.58M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | CAD | CAD | CAD | CAD | CAD | CAD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
| Revenue | $427K | $390K | $181K | $81K | $0 | $0 |
| YoY Growth | 9.5% | 115.3% | 124.3% | - | - | - |
| Cost of Revenue | $2.5M | $119K | $338K | $27K | $0 | $0 |
| Gross Profit | -$2.08M | $271K | -$157K | $54K | $0 | $0 |
| Gross Margin | -486.4% | 69.5% | -86.7% | 66.8% | - | - |
| Research and Development | $348K | $144K | $152K | $133K | $241K | $0 |
| Selling, General, and Administrative | $2.72M | $3.99M | $3.93M | $6.14M | $5.06M | $483K |
| Other | -$611K | $1.74M | $138K | $1.17M | $752K | $0 |
| Total Operating Expenses | $2.46M | $5.88M | $4.22M | $7.44M | $6.06M | $483K |
| Operating Income (EBIT) | -$4.53M | -$5.61M | -$4.38M | -$7.39M | -$6.06M | -$483K |
| Operating Margin | -1062.3% | -1438.8% | -2419.1% | -9155.2% | - | - |
| Interest Expense | $532K | $429K | $44K | $28K | $19K | $8K |
| Interest Income | $14K | $3K | $136K | $67K | $55K | $0 |
| Other Income (Expense) | $818K | -$427K | -$814K | $39K | $36K | -$24K |
| Income Before Tax (EBT) | -$3.72M | -$6.04M | -$5.19M | -$7.35M | -$6.02M | -$508K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$3.72M | -$6.04M | -$5.19M | -$7.35M | -$6.02M | -$508K |
| Net Income Margin | -870.8% | -1548.3% | -2868.5% | -9106.9% | - | - |
| Supplementary Data | ||||||
| EPS | -1.16 | -2.02 | -1.79 | -2.70 | -0.12 | -1.12 |
| Diluted EPS | -1.16 | -2.02 | -1.79 | -2.70 | -0.12 | -1.12 |
| Weighted Average OS | 3.20M | 2.98M | 2.90M | 2.60M | 51.92M | 455,026 |
| EBITDA | -$2.23M | -$4.74M | -$4.42M | -$7.03M | -$5.95M | -$494K |
| EBITDA Margin | -523.4% | -1215.5% | -2441.5% | -8708.5% | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | CAD | CAD | CAD | CAD | CAD | CAD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
| Assets | ||||||
| Current Assets | ||||||
| Cash and Cash Equivalents | $1.14M | $104K | $1.34M | $1.89M | $8.43M | $4.47M |
| Short-Term Investments | $5K | $0 | $0 | $0 | $4M | $0 |
| Cash and Short-Term Investments | $1.15M | $104K | $1.34M | $1.89M | $12.43M | $4.47M |
| Accounts Receivable | $95K | $124K | $166K | $99K | $188K | $83K |
| Inventory | $311K | $895K | $779K | $265K | $123K | $48K |
| Other Current Assets | $4 | $0 | $0 | $0 | -$123K | $20K |
| Total Current Assets | $1.83M | $1.23M | $2.43M | $2.43M | $14.3M | $4.62M |
| Long-Term Assets | ||||||
| Property, Plant & Equipment Net | $12.58M | $13.3M | $14.05M | $14.39M | $8.9M | $1.52M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $827K | $18K | $16K | $11K | $258K | $29K |
| Total Long-Term Assets | $13.41M | $13.32M | $14.06M | $14.4M | $9.16M | $1.55M |
| Other Assets | $0 | $55 | $0 | -$8K | $0 | $0 |
| Total Assets | $15.23M | $14.55M | $16.49M | $16.82M | $23.46M | $6.17M |
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts Payable | $1.19M | $749K | $902K | $556K | $2.11M | $647K |
| Short-Term Debt | $6.37M | $960K | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $208K | $116K | $113K | -$556K | $0 | -$647K |
| Other Current Liabilities | $499K | $0 | $0 | $556K | $0 | $726K |
| Total Current Liabilities | $8.5M | $3.22M | $1.61M | $728K | $2.24M | $752K |
| Long-Term Liabilities | ||||||
| Long-Term Debt | $159K | $1.76M | $1.64M | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | -$159K | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $159K | $1.76M | $1.67M | $69K | $155K | $131K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $8.65M | $4.98M | $3.28M | $798K | $2.4M | $883K |
| Stockholders' Equity | ||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $31.74M | $31.16M | $28.7M | $26.61M | $25.16M | $966K |
| Retained Earnings | -$27.28M | -$23.61M | -$17.65M | -$13.43M | -$6.19M | -$169K |
| Comprehensive Income & Other | $2.12M | $2.03M | $2.16M | $2.83M | $2.1M | $4.49M |
| Other Stockholders' Equity | $2.12M | $2.03M | $2.16M | $2.83M | $2.1M | $4.49M |
| Total Equity | $6.58M | $9.58M | $13.21M | $16.02M | $21.07M | $5.29M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $15.23M | $14.55M | $16.49M | $16.82M | $23.46M | $6.17M |
| Supplementary Data | ||||||
| Total Debt | $6.69M | $2.75M | $1.71M | $158K | $251K | $156K |
| Net Debt | $5.55M | $2.65M | $362K | -$1.73M | -$8.18M | -$4.31M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | CAD | CAD | CAD | CAD | CAD | CAD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
| Operating Activities | ||||||
| Net Income | -$3.71M | -$6.04M | -$5.19M | -$7.35M | -$6.02M | -$169K |
| Depreciation & Amortization | $950K | $868K | $730K | $294K | $47K | $6K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $46K | $60K | $163K | $1.01M | $1.26M | $0 |
| Changes in Working Capital: | ||||||
| Accounts Receivable | $29K | $42K | -$67K | $89K | -$105K | -$64K |
| Inventory | $501K | $24K | -$213K | -$265K | $0 | $0 |
| Accounts Payable | -$46K | -$129K | $643K | $122K | $260K | $0 |
| Other Working Capital | $763K | $819K | $464K | $1.51M | -$1.64M | $84K |
| Total Working Capital Change | $1.25M | $756K | $827K | $1.45M | -$1.49M | $20K |
| Other Non-Cash Items | -$1.16M | $71K | -$127K | $21K | $177K | -$316 |
| Net Cash from Operating | -$2.63M | -$4.28M | -$3.6M | -$4.58M | -$6.02M | -$143K |
| Investing Activities | ||||||
| Capital Expenditures | -$88K | -$152K | -$804K | -$898K | -$4.94M | -$755K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | -$4M | $0 |
| Sales of Investments | $0 | $0 | $0 | $4M | $0 | $0 |
| Other Investing Activities | $0 | -$2K | $98K | -$6.25M | -$258K | $0 |
| Net Cash from Investing | -$88K | -$154K | -$706K | -$3.15M | -$9.19M | -$755K |
| Financing Activities | ||||||
| Debt Repaid | $47K | -$958K | -$1.92M | $111K | $49K | - |
| Common Stock Issuance | $395K | $2.04M | $1.84M | $1.3M | $18.86M | $5.44M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$40K | $200K | $0 | $0 | $364K | $5.37M |
| Net Cash from Financing | $3.76M | $3.19M | $3.76M | $1.19M | $19.18M | $5.37M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $1.04M | -$1.24M | -$544K | -$6.54M | $3.96M | $4.47M |
| Supplementary Data | ||||||
| Operating Cash Flow | -$2.63M | -$4.28M | -$3.6M | -$4.58M | -$6.02M | -$143K |
| Capital Expenditure | -$88K | -$152K | -$804K | -$7.15M | -$4.94M | -$755K |
| Free Cash Flow | -$2.72M | -$4.43M | -$4.41M | -$11.73M | -$10.96M | -$898K |
| Cash at Beginning | $104K | $1.34M | $1.89M | $8.43M | $4.47M | $48K |
| Cash at End | $1.15M | $104K | $1.34M | $1.89M | $8.43M | $4.52M |